Recombinant PDCD1 (Camrelizumab Biosimilar) 抗体
This anti-PDCD1 (Camrelizumab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting PDCD1 (Camrelizumab Biosimilar) in ELISA. Suitable for 人.
Quick Overview for Recombinant PDCD1 (Camrelizumab Biosimilar) 抗体 (ABIN7488116)
抗原
PDCD1 (Camrelizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This PDCD1 (Camrelizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Camrelizumab Biosimilar - Anti-PDCD1, PD-1, CD279 mAb
-
产品特性
- Antibody Type: IgG4-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG4 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- PDCD1 (Camrelizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
SHR-1210
Camrelizumab is an IgG4κ humanized monoclonal antibody being investigated for hepatocellular carcinoma. It targets programmed cell death protein 1 (PD-1), a protein on the surface of cells, also known as CD279 (cluster of differentiation 279). -
CAS-编号
- 1798286-48-2
抗原
-
You are here:
